InsiderPulseNo transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2021-01-04 | Christopher L. Jacobs(D-NY27) | house | Sale | $1,001 - $15,000 |
| 2020-12-28 | Christopher L. Jacobs(D-NY27) | house | Purchase | $1,001 - $15,000 |
No financial data available for RETA.
Company may not file with SEC or CIK is unresolved.
Biogen: LEQEMBI's $10 Billion Potential
Reata shareholders clear buyout deal with Biogen
Catalyst watch: Microsoft, Amazon, Oracle, and Intel to Hold High-Profile Events
Reata Pharmaceuticals climbs as HSR waiting period for sale to Biogen expired
Latest U.S. Zombie Firms With The Highest Potential Credit Risks, Plus 6-Month Update
HSBC bullish on IQVIA, Zoetis, bluebird, Actinium; bearish on Gilead
Sanofi was mystery suitor in Reata Pharma bidding war - report
Second Half Outlook For Biotech Stocks